Oral Bioavailability and Protease Resistance Unlike true peptides, Dihexa resists gastrointestinal peptidase degradation due to its peptidomimetic structure
CJC-1295 (2mg/kg s.c.) produces GH peak at 2-3 hours, measurable hepatic IGF-1 mRNA induction at 4-6 hours, circulating IGF-1 elevation at 6-10 hours, and skeletal muscle protein synthesis augmentation (SUnSET) at 8-16 hours post-injection with sustained elevation for 3-5 days due to DAC half-life
Should I Tell My Prescriber
These delivery methods ensure that ozones therapeutic benefits reach the target areas effectively, potentially offering relief from chronic joint pain with minimal side effects when administered according to precise protocols
Because BPC-157 was originally derived from gastric juice, oral delivery remains an active area of research, and oral BPC products are among the formulations being explored for potential gut-targeted applications alongside injectable formulations